Redhawk Wealth Advisors’s GSK GSK Stock Holding History

Redhawk Wealth Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.56M	Buy	29,746 +1,520	+5%	+$80.4K	0.15%	141
2026 Q1	$1.56M	Buy	+28,226	New	+$1.53M	0.17%	134
2022 Q3	–	Sell	-3,984	Closed	-$217K	–	168
2022 Q2	$217K	Buy	3,984 +3	+0.1%	+$166	0.1%	153
2022 Q1	$217K	Buy	3,981 +3	+0.1%	+$163	0.06%	190
2021 Q4	$219K	Buy	+3,978	New	+$207K	0.06%	209
2019 Q3	–	Sell	-254	Closed	-$13K	–	250
2019 Q2	$13K	Buy	+254	New	+$12.7K	0.01%	344

Other funds holding GSK

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

TNB

Thomasville National Bank Thomasville, Georgia $1.82B AUM

ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return

SIS

Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return

KFP

Keystone Financial Planning Cleveland, Ohio $388M AUM 16.66% 1-Year Est. Return

QCM

QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return

Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return

Bell Bank Fargo, North Dakota $2.62B AUM 23.93% 1-Year Est. Return

KIC

Keating Investment Counselors Delray Beach, Florida $364M AUM 22.11% 1-Year Est. Return

Redhawk Wealth Advisors's GSK Position: Q2 2026 in Review

Redhawk Wealth Advisors increased its GSK (GSK) stake by 5.4% in Q2 2026, buying an estimated $80.4K and bringing the position to 29,746 shares worth $1.56M. The position accounts for 0.15% of the portfolio, ranked #141.

Redhawk Wealth Advisors first reported a position in GSK in Q2 2019 and has held it in 6 quarters since. 198 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Redhawk Wealth Advisors held 29,746 shares of GSK worth $1.56M as of Q2 2026.
Redhawk Wealth Advisors bought 1,520 GSK shares in Q2 2026, an estimated $80.4K.
GSK made up 0.15% of Redhawk Wealth Advisors's portfolio in Q2 2026, its #141 holding.
Redhawk Wealth Advisors first reported a position in GSK in Q2 2019 and has held it in 6 quarters since.
198 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Redhawk Wealth Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.